Sichuan Cancer Hospital & Institute赞助的临床试验
总计3929个结果
-
Shandong Cancer Hospital and Institute未知
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & Institute完全的
-
Peking University Cancer Hospital & Institute完全的
-
Peking University Cancer Hospital & Institute招聘中
-
Peking University Cancer Hospital & Institute招聘中
-
Peking University Cancer Hospital & Institute尚未招聘
-
Peking University Cancer Hospital & Institute招聘中
-
Peking University Cancer Hospital & Institute招聘中HER2阳性转移性乳腺癌 | 以前接受过曲妥珠单抗治疗 | 曲妥珠单抗联合帕妥珠单抗和化疗中国
-
Peking University Cancer Hospital & Institute招聘中
-
Peking University Cancer Hospital & Institute尚未招聘
-
Peking University Cancer Hospital & Institute完全的
-
Peking University Cancer Hospital & Institute主动,不招人
-
Peking University Cancer Hospital & Institute未知